Target intelligence / Profile preview

Eukaryotic translation initiation factor 1 pseudogene 1 (EIF1P1)

Target
EIF1P1
Molecular classification
Other
01

Overview

EIF1P1 is classified as a pseudogene of the *eukaryotic translation initiation factor 1* (EIF1), meaning it is a nonfunctional genomic sequence similar to the protein-coding gene EIF1, but it does not produce a functional protein product. Pseudogenes like EIF1P1 typically arise via duplication or retrotransposition, subsequently losing their protein-coding potential due to mutations or lack of regulatory elements[2][4]. Therefore, EIF1P1 is not considered a therapeutic target (such as a receptor, enzyme, transporter, etc.), nor does it have a well-characterized function, involvement in disease, drug interactions, or a mechanism of action. The user query refers to a "target molecule/receptor", but EIF1P1 is a pseudogene and not an actual enzyme, receptor, or molecular target. Information about biological functions, disease roles, drug interactions, or biomarker status is not applicable to pseudogenes unless specific evidence establishes a noncoding regulatory function, which is not the case for EIF1P1 in current scientific literature[2][4]. For genuine information on the active translation initiation factor, one should refer to "eukaryotic translation initiation factor 1 (EIF1)" rather than its pseudogene. EIF1 itself is a universally conserved protein essential for the scanning and initiation site selection process during translation[2][4].

Other names
EIF1P1eIF1 pseudogene 1

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 1 pseudogene 1 (EIF1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 1 pseudogene 1 (EIF1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call